Neurologic aspects of 49,XXXXY syndrome

Journal of Child Neurology

Volumn 18, Issue 7, 2003, Pages 501-504

  Galasso, Cinzia ^a   Arpino, Carla ^a   Fabbri, Francesca ^b   Curatolo, Paolo ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; TESTOSTERONE; VALPROIC ACID;

ADOLESCENT; BEHAVIOR DISORDER; BONE DISEASE; CASE REPORT; CHROMOSOME ANALYSIS; CLINICAL FEATURE; COGNITIVE DEFECT; CRANIOFACIAL MALFORMATION; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; FEMALE; GENITAL MALFORMATION; HEMISPHERE; HORMONAL THERAPY; HUMAN; KARYOTYPE 49,XXXXY; LANGUAGE DISABILITY; MENTAL DEFICIENCY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEIZURE; SEX CHROMOSOME ABERRATION; SPEECH DISORDER; SUPPLEMENTATION;

EID: 0042924234     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738030180071001     Document Type: Review

References (18)

1. Peet J, Weaver DD, Vance GH: 49,XXXXY: A distinct phenotype. Three new cases and review. J Med Genet 1998;35:420-424.
2. Curfs LMG, Schreppers-Tijdink G, Wiegers A, et al: The 49,XXXXY syndrome: Clinical and psychological findings in five patients. J Ment Defic Res 1990;34:277-282.
3. Dotsch J, Foersteb W, Holl R, et al: Case of 49XXXXY syndrome. Development throughout adolescence and endocrine aspects. Horm Res 2000;53:154-156.
4. Borghgraef M, Fryns JP, Smeets E, et al: The 49,XXXXY syndrome. Clinical and psychological follow-up data. Clin Genet 1988;33:429-434.
5. Lomelino CA, Reiss AL: 49,XXXXY syndrome: Behavioural and developmental profiles. J Med Genet 1991;28:609-612.
6. Verrotti A, Chiarelli F, Violante N, et al: La sindrome 49,XXXXY. Descrizione di due casi clinici. Pediatr Med Chir 1986;8:575-578.
7. Linden MG, Bender BG, Robinson A: Sex chromosome tetrasomy and pentasomy. Pediatrics 1995;96:672-682.
8. Haeusler G, Frisch H, Guchev Z, et al: Hypoplasia of the corpus callosum and growth hormone deficiency in the XXXXY syndrome. Am J Med Genet 1992;44:230-232.
9. Sheridan MK, Radlinski SS, Kennedy MD: Developmental outcome in 49,XXXXY Klinefelter syndrome. Dev Med Child Neurol 1990; 32:528-546.
10. Elia M, Musumeci SA, Ferri R, et al: Seizures in Klinefelter's syndrome: A clinical and EEG study of five patients. Ital J Neurol Sci 1995; 16:231-238.
11. Warwick MM, Doody GA, Lawrie SM, et al: Volumetric magnetic resonance imaging study of the brain in subject with sex chromosome aneuploidies. J Neurol Neurosurg Psychiatry 1999;66:628-632.
12. Netley C, Rovet J: Verbal deficits in children with 47,XXY and 47,XXX karyotypes: A descriptive and experimental study. Brain Lang 1982;17:58-72.
13. Graham JM, Bashir AS, Stark RE, et al: Oral and written language abilities of XXY boys: Implications for anticipatory guidance. Pediatrics 1988;81:795-806.
14. Nielsen J, Pelsen B, Sorensen K: Follow-up of 30 Klinefelter males treated with testosterone. Clin Genet 1988;33:262-269.
15. Seidman SN, Rabkin JG: Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. J Affect Disord 1998;48:157-161.
16. Cooper MA, Ritchie EC: Testosterone repalcement therapy for anxiety. Am J Psychiatry 2000;157:1884.
17. Moffat SD, Hampson E, Wickett JC, et al: Testosterone is correlated with regional morphology of the human corpus callosum. Brain Res 1997;767:297-304.
18. Diamond MC: Hormonal effects of the development of cerebral lateralization. Psychoneuroendocrinology 1991;16:121-129.